asthma 2009
... attacks of breathlessness and wheezing, which vary in severity and frequency from person to person. In an individual, they may occur from hour to hour and day to day. • This condition is due to inflammation of the air passages in the lungs and affects the sensitivity of the nerve endings in the airw ...
... attacks of breathlessness and wheezing, which vary in severity and frequency from person to person. In an individual, they may occur from hour to hour and day to day. • This condition is due to inflammation of the air passages in the lungs and affects the sensitivity of the nerve endings in the airw ...
Eye Movement Desensitization and Reprocessing
... Evidence supporting the efficacy of EMDR has advanced from case reports to well-controlled randomized trials and multiple, systematic meta-analytic reviews. Consequently, this critical review of the evidence is based exclusively on a review of randomized controlled trials (RCTs) of EMDR for PTSD p ...
... Evidence supporting the efficacy of EMDR has advanced from case reports to well-controlled randomized trials and multiple, systematic meta-analytic reviews. Consequently, this critical review of the evidence is based exclusively on a review of randomized controlled trials (RCTs) of EMDR for PTSD p ...
Levodopa-Carbidopa Intestinal Gel
... completing the trial. The results demonstrated a statistically significant and clinically meaningful improvement with levodopa/carbidopa intestinal gel (LCIG) compared with oral LC-IR with respect to the primary efficacy endpoint (change in OFF time) and the key secondary efficacy measure (ON time w ...
... completing the trial. The results demonstrated a statistically significant and clinically meaningful improvement with levodopa/carbidopa intestinal gel (LCIG) compared with oral LC-IR with respect to the primary efficacy endpoint (change in OFF time) and the key secondary efficacy measure (ON time w ...
PDF
... [9-11]. Symptom intensity (SI) was assessed using a visual analogue scale (ranging from 1 to 9) [12]. Consulting behaviour and the number of examinations were evaluated using a questionnaire about consultation frequencies and examinations before and after diagnosing. The duration of the disease, cli ...
... [9-11]. Symptom intensity (SI) was assessed using a visual analogue scale (ranging from 1 to 9) [12]. Consulting behaviour and the number of examinations were evaluated using a questionnaire about consultation frequencies and examinations before and after diagnosing. The duration of the disease, cli ...
Holzbauer et al., 2010
... years), and 24 (47%) of 51 HCWs re ported unprotected exposure to patients with confirmed 2009 H1N1 influenza (Ta ble 1). Nurses were the most frequently exposed (26 [51%] of 51 exposed HCWs), and most exposures occurred on medical units (30 [59%] of 51 exposed HCWs). According to multivariate analy ...
... years), and 24 (47%) of 51 HCWs re ported unprotected exposure to patients with confirmed 2009 H1N1 influenza (Ta ble 1). Nurses were the most frequently exposed (26 [51%] of 51 exposed HCWs), and most exposures occurred on medical units (30 [59%] of 51 exposed HCWs). According to multivariate analy ...
The Rip Van Winkle Effect
... Once the patient is safely in therapy and on the road to reintegration many families start having problems. A prime problem is the fact that while one is addicted; they simply do not count in family decisions. By that I mean that they check out at any indication of conflict. They take no responsibil ...
... Once the patient is safely in therapy and on the road to reintegration many families start having problems. A prime problem is the fact that while one is addicted; they simply do not count in family decisions. By that I mean that they check out at any indication of conflict. They take no responsibil ...
Module Description Template
... and advise nursing and medical staff on the safe practice when mixing drugs and fluids in a bag, line or syringe. Make recommendations on the handling, storage and administration of parenteral drugs so that they remain safe and efficacious for their allocated shelf life. Discuss the provision of adv ...
... and advise nursing and medical staff on the safe practice when mixing drugs and fluids in a bag, line or syringe. Make recommendations on the handling, storage and administration of parenteral drugs so that they remain safe and efficacious for their allocated shelf life. Discuss the provision of adv ...
Functional Neuroimaging in Psychiatry
... and pathology of perception and cognition and has become an indispensable tool for psychological, neurological, and psychiatric research. Its clinical applications, however, remain very limited at present. Its most important current use is for preoperative brain mapping. In psychiatry, fMRI has led ...
... and pathology of perception and cognition and has become an indispensable tool for psychological, neurological, and psychiatric research. Its clinical applications, however, remain very limited at present. Its most important current use is for preoperative brain mapping. In psychiatry, fMRI has led ...
Approval based on Phase 3 RESONATE TM- 2 trial
... Atrial Fibrillation - Atrial fibrillation and atrial flutter (range, 6% to 9%) have occurred in patients treated with IMBRUVICA®, particularly in patients with cardiac risk factors, hypertension, acute infections, and a previous history of atrial fibrillation. Periodically monitor patients clinicall ...
... Atrial Fibrillation - Atrial fibrillation and atrial flutter (range, 6% to 9%) have occurred in patients treated with IMBRUVICA®, particularly in patients with cardiac risk factors, hypertension, acute infections, and a previous history of atrial fibrillation. Periodically monitor patients clinicall ...
Mental/emotional state
... It is measured using especially designed and tested instruments which quantifies people’s abilities to function in the ordinary tasks of living. (Psychooncology 2008) QoL measures may therefore help to decide between different treatments, to inform patients about the likely effects of treatments, ...
... It is measured using especially designed and tested instruments which quantifies people’s abilities to function in the ordinary tasks of living. (Psychooncology 2008) QoL measures may therefore help to decide between different treatments, to inform patients about the likely effects of treatments, ...
Document
... benzathine penicillin 2.4 MU IM once per week for 3 weeks. • Suggested treatment for possibility of coexisting latent infection is 3 additional doses of benzathine penicillin. – Based on pathophysiology of organism and safety of drug. – No clinical trial data available. ...
... benzathine penicillin 2.4 MU IM once per week for 3 weeks. • Suggested treatment for possibility of coexisting latent infection is 3 additional doses of benzathine penicillin. – Based on pathophysiology of organism and safety of drug. – No clinical trial data available. ...
Management of Excessive Respiratory Secretions: A Sharing of Two
... the lung and inhibiting the synthesis and secretion of a mucus secretogogue from pulmonary macrophages.7 There were case reports of using oral clarithromycin combined with inhaled beclomethasone in managing bronchorrhea in alveolar cell carcinoma,8 pulsed methylprednisolone in a patient with bronchi ...
... the lung and inhibiting the synthesis and secretion of a mucus secretogogue from pulmonary macrophages.7 There were case reports of using oral clarithromycin combined with inhaled beclomethasone in managing bronchorrhea in alveolar cell carcinoma,8 pulsed methylprednisolone in a patient with bronchi ...
Specialist Working Group for Haematology Proposed changes to the
... (B) Progressive (C) Programmed ...
... (B) Progressive (C) Programmed ...
NorDItroPIN® NorDILet® 5 mg/1.5 mL NOVO NORDISK A/S
... mass, decreasing fat mass as well as increasing height in patients with Prader-Willi syndrome. Scoliosis may progress in any child during rapid growth. Signs of scoliosis should be monitored during treatment. However, growth hormone treatment has not been shown to increase the incidence or severity ...
... mass, decreasing fat mass as well as increasing height in patients with Prader-Willi syndrome. Scoliosis may progress in any child during rapid growth. Signs of scoliosis should be monitored during treatment. However, growth hormone treatment has not been shown to increase the incidence or severity ...
Clinical Study Report
... 24 patients out of 39 screened in this study were included. All of the patients were administered with the test drug and completed the treatment period. The mITT group for efficacy analysis and the safety evaluation group were determined as analysis subject and no cases were excluded. Demography cha ...
... 24 patients out of 39 screened in this study were included. All of the patients were administered with the test drug and completed the treatment period. The mITT group for efficacy analysis and the safety evaluation group were determined as analysis subject and no cases were excluded. Demography cha ...
No Slide Title
... the diagnosis, management and prevention of COPD” • An international panel which consists of specialists in the areas of respiratory medicine, epidemiology, socioeconomics, public health & health education • GOLD aims to increase awareness of COPD and decrease morbidity and mortality ...
... the diagnosis, management and prevention of COPD” • An international panel which consists of specialists in the areas of respiratory medicine, epidemiology, socioeconomics, public health & health education • GOLD aims to increase awareness of COPD and decrease morbidity and mortality ...
Multiple Sclerosis — Part 4 - Audio
... exchange if patient unresponsive to corticosteroids; preventing recurrence — interferon-β and natalizumab ineffective (possibly associated with harm); best evidence for efficacy with azathioprine, mycophenolate mofetil, and rituximab; no comparative efficacy studies available, but these agents appea ...
... exchange if patient unresponsive to corticosteroids; preventing recurrence — interferon-β and natalizumab ineffective (possibly associated with harm); best evidence for efficacy with azathioprine, mycophenolate mofetil, and rituximab; no comparative efficacy studies available, but these agents appea ...
here - NovaVive Inc.
... GLOBAL CONCERN: Antibiotics are frequently administered to the horse suffering from Equine Respiratory Disease Complex, which is usually caused by a virus or combination of viruses. RESPONSIBILITY: Veterinarians are expected, by horse owners, to treat the disease with antibiotics, despite knowing th ...
... GLOBAL CONCERN: Antibiotics are frequently administered to the horse suffering from Equine Respiratory Disease Complex, which is usually caused by a virus or combination of viruses. RESPONSIBILITY: Veterinarians are expected, by horse owners, to treat the disease with antibiotics, despite knowing th ...
White blood cells (green) attack a cancerous cell (blue) in a
... Allison licensed his antibody to Medarex in 1999, and so started a 12-year journey to commercialization. His antibody eventually became Yervoy, approved in 2011 as the first of a new class of drugs called checkpoint inhibitors. Medarex was purchased in 2009 by Bristol-Myers, its development partner, ...
... Allison licensed his antibody to Medarex in 1999, and so started a 12-year journey to commercialization. His antibody eventually became Yervoy, approved in 2011 as the first of a new class of drugs called checkpoint inhibitors. Medarex was purchased in 2009 by Bristol-Myers, its development partner, ...
2016 Update to Heart Failure Clinical Practice Guidelines
... patients that efficacious therapies have been demonstrated to date. Also referred to as diastolic HF. Several different criteria have been used to further define HFpEF. The diagnosis of HFpEF is challenging because it is largely one of excluding other potential noncardiac causes of symptoms suggesti ...
... patients that efficacious therapies have been demonstrated to date. Also referred to as diastolic HF. Several different criteria have been used to further define HFpEF. The diagnosis of HFpEF is challenging because it is largely one of excluding other potential noncardiac causes of symptoms suggesti ...
JRA
... Infliximab and adalimumab, monoclonal antibodies to TNF alpha also have been used with varying success in children with systemic JRA biological agents that target IL-1 and IL-6 activity, such as anakinra and thalidomide, human recombinant anti-interleukin-6 monoclonal ...
... Infliximab and adalimumab, monoclonal antibodies to TNF alpha also have been used with varying success in children with systemic JRA biological agents that target IL-1 and IL-6 activity, such as anakinra and thalidomide, human recombinant anti-interleukin-6 monoclonal ...
Controversies in Sleep Physiology and Sleep Medicine
... The use of amphetamines in medicine has been subject to controversy worldwide. Several European countries have banned amphetamines because of their side effects, and the U.S. has considered banning its medical use. The countries that do allow amphetamines often require triplicate prescriptions and d ...
... The use of amphetamines in medicine has been subject to controversy worldwide. Several European countries have banned amphetamines because of their side effects, and the U.S. has considered banning its medical use. The countries that do allow amphetamines often require triplicate prescriptions and d ...
highlights of prescribing information
... Mesalamine has been associated with an acute intolerance syndrome that may be difficult to distinguish from an exacerbation of ulcerative colitis. Although the exact frequency of occurrence has not been determined, it has occurred in 3% of patients in controlled clinical trials of mesalamine or sulf ...
... Mesalamine has been associated with an acute intolerance syndrome that may be difficult to distinguish from an exacerbation of ulcerative colitis. Although the exact frequency of occurrence has not been determined, it has occurred in 3% of patients in controlled clinical trials of mesalamine or sulf ...
No-Needle Mesotherapy™ lIpo KoNtoUr
... and has the same molecular structure as the human body PPC. It is focused on dissolving of unwanted small localized areas of fat. In addition to small areas of fat-loss, stretch-mark, and cellulite reduction, the treatment may improve skin tone, elasticity, and increase collagen production that is i ...
... and has the same molecular structure as the human body PPC. It is focused on dissolving of unwanted small localized areas of fat. In addition to small areas of fat-loss, stretch-mark, and cellulite reduction, the treatment may improve skin tone, elasticity, and increase collagen production that is i ...
5. - Apccm
... COPD.Despite optimal pharmacologic therapy, patients with COPD often have symptoms severe enough to limit normal physical activities of daily living and affect quality of life.Proactive diagnosis and evidence-based management can alleviate the impact of COPD on patients' lives. Nowadays public is aw ...
... COPD.Despite optimal pharmacologic therapy, patients with COPD often have symptoms severe enough to limit normal physical activities of daily living and affect quality of life.Proactive diagnosis and evidence-based management can alleviate the impact of COPD on patients' lives. Nowadays public is aw ...
Management of multiple sclerosis
Several therapies for multiple sclerosis (MS) exist, although there is no known cure. Multiple sclerosis is a chronic inflammatory demyelinating disease that affects the central nervous system (CNS).The most common initial course of the disease is the relapsing-remitting subtype, which is characterized by unpredictable attacks (relapses) followed by periods of relative remission with no new signs of disease activity. After some years, many of the people who have this subtype begin to experience neurologic decline without acute relapses. When this happens it is called secondary progressive multiple sclerosis. Other, less common, courses of the disease are the primary progressive (decline from the beginning without attacks) and the progressive-relapsing (steady neurologic decline and superimposed attacks). Different therapies are used for patients experiencing acute attacks, for patients who have the relapsing-remitting subtype, for patients who have the progressive subtypes, for patients without a diagnosis of MS who have a demyelinating event, and for managing the various consequences of MS.The primary aims of therapy are returning function after an attack, preventing new attacks, and preventing disability. As with any medical treatment, medications used in the management of MS may have several adverse effects, and many possible therapies are still under investigation. At the same time different alternative treatments are pursued by many patients, despite the paucity of supporting, comparable, replicated scientific study.This article focuses on therapies for standard MS; borderline forms of MS have particular treatments that are excluded.